Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides

Haemophilia

Volumn 16, Issue 1, 2010, Pages 143-147

  Uprichard, J ^a   Dazzi, F ^a   Apperley, J F ^a   Laffan, M A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Allo HSCT; FVIII; Haemophilia; Inhibitor; Tolerance

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ALEMTUZUMAB; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOSPORIN A; FAHNDI; FLUDARABINE; HLA ANTIGEN; MELPHALAN; METHOTREXATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RITUXIMAB; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHROPATHY; ARTHROPLASTY; ARTICLE; BLEEDING; BLOOD CULTURE; CASE REPORT; CONTINUOUS INFUSION; DEATH; DISEASE SEVERITY; DONOR; DRUG DOSE INCREASE; FEVER; GRAFT VERSUS HOST REACTION; HEART ARREST; HEMARTHROSIS; HEMOPHILIA A; HLA MATCHING; HUMAN; IMMOBILIZATION; IMMUNOADSORPTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; KLEBSIELLA PNEUMONIAE; MALE; MEMORY CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REDUCED INTENSITY CONDITIONING; SEPTICEMIA; SIBLING; TRANSPLANTATION TOLERANCE; WHEELCHAIR;

ADULT; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR VIII; FATAL OUTCOME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; SEPSIS; YOUNG ADULT;

EID: 73949112756     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02099.x     Document Type: Article

References (21)

1. Haya S, Moret A, Cid AR. Inhibitors in haemophilia A: current management and open issues. Haemophilia 2007, 13:52-60.
2. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006, 133:591-605.
3. Mariani G, Kroner B. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success. Haematologica 2001, 86:1186-93.
4. DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost 2002, 87:52-7.
5. Lenk H. The German Registry of immune tolerance treatment in hemophilia--1999 update. Haematologica 2000, 85:45-7.
6. Ewenstein BM, Hoots WK, Lusher JM. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors. Haematologica 2000, 85:35-9.
7. Barrow RT, Healey JF, Gailani D, Scandella D, Lollar P. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules. Blood 2000, 95:564-8.
8. Dazzi F, van Laar JM, Cope A, Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther 2007, 9:206.
9. Nadal E, Garin M, Kaeda J, Apperley J, Lechler R, Dazzi F. Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2007, 21:472-9.
10. Vukmanovic-Stejic M, Zhang Y, Cook JE. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006, 116:2423-33.
11. Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2008, 21:579-96.
12. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005, 435:620-7.
13. Van Leeuwen EF, Mauser-Bunschoten EP, Van Dijken PJ, Kok AJ, Sjamsoedin-Visser EJ, Sixma JJ. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose. Br J Haematol 1986, 64:291-7.
14. Nilsson IM, Berntorp E, Freiburghaus C. Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 1993, 70:56-9.
15. Weng L, Dyson J, Dazzi F. Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment. Proc Natl Acad Sci USA 2007, 104:8415-20.
16. Kawai T, Cosimi AB, Spitzer TR. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008, 358:353-61.
17. Griffith LM, McCoy JP, Bolan CD. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005, 128:668-75.
18. Marmont AM. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 2008, 30:145-50.
19. Burt RK, Traynor AE, Craig R, Marmont AM. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003, 31:521-4.
20. Snowden JA, Kearney P, Kearney A. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998, 41:453-9.
21. Van Wijmeersch B, Sprangers B, Rutgeerts O. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect. Biol Blood Marrow Transplant 2007, 13:627-37.